Sionna Therapeutics (SION) Cash from Operations (2024 - 2026)
Sionna Therapeutics (SION) posted Cash from Operations of 21840000.0 for Q1 2026, down 31.36% sequentially from 16626000.0 in Q4 2025, and down 34.09% YoY from 33134307.0 in Q1 2025.
Sionna Therapeutics (SION) Cash from Operations (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Cash from Operations for 3 years, with the latest figure at 21840000.0 in Q1 2026.
- Quarterly Cash from Operations fell 34.09% year-over-year to 21840000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71849000.0 (down 28.53% YoY) and the FY2025 annual result came in at 66297000.0, down 25.59% from the prior year.
- Cash from Operations declined to 21840000.0 in Q1 2026 per SION's latest filing, from 16626000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 10145000.0 in Q2 2024 and troughed at 21840000.0 in Q1 2026.
- A 3-year average of 15658222.22 and a median of 16288000.0 in 2025 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 13.89% in 2025, down 78.94% in 2025.
- Over 3 years, Cash from Operations stood at 11781000.0 in 2024, then slumped by 41.13% to 16626000.0 in 2025, then slumped by 31.36% to 21840000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 21840000.0, 16626000.0, and 15230000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | -22.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.22 Mn |
| Jun 30, 2026 | -22.22 Mn |
| Mar 31, 2026 | -21.84 Mn |
| Mar 31, 2026 | -21.84 Mn |
| Dec 31, 2025 | -16.63 Mn |
| Dec 31, 2025 | -16.63 Mn |
| Sep 30, 2025 | -15.23 Mn |
| Sep 30, 2025 | -15.23 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Mar 31, 2025 | -16.29 Mn |
| Mar 31, 2025 | -16.29 Mn |
| Dec 31, 2024 | -11.78 Mn |
| Dec 31, 2024 | -11.78 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Mar 31, 2024 | -13.18 Mn |
| Mar 31, 2024 | -13.18 Mn |